Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

QGEN – Qiagen N.V.

Qiagen N.V.
QGEN
$47.90
Name : Qiagen N.V.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $10,371,949,568.00
EPSttm : 0.43
finviz dynamic chart for QGEN
Qiagen N.V.
$47.90
0.26%
$0.125

Float Short %

2.63

Margin Of Safety %

-2

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.03

EPS Last/This Y

1.97

EPS This/Next Y

0.2

Price

47.76

Target Price

50.14

Analyst Recom

2

Performance Q

20.48

Relative Volume

1.25

Beta

0.69

Ticker: QGEN




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02QGEN44.90.110.004237
2025-06-03QGEN45.310.122.134057
2025-06-04QGEN45.720.13999.994160
2025-06-05QGEN45.590.130.504158
2025-06-06QGEN45.480.130.084159
2025-06-09QGEN46.170.132.334778
2025-06-10QGEN46.220.1413.754786
2025-06-11QGEN46.720.1512.754832
2025-06-12QGEN47.40.170.004919
2025-06-13QGEN47.120.170.094919
2025-06-16QGEN47.440.170.094919
2025-06-17QGEN46.570.170.004899
2025-06-18QGEN46.560.170.004900
2025-06-20QGEN46.770.17999.994915
2025-06-23QGEN46.710.174.004582
2025-06-24QGEN47.220.170.224586
2025-06-25QGEN47.460.170.104595
2025-06-26QGEN48.030.160.015041
2025-06-27QGEN47.770.150.005191
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02QGEN44.916.3441.02.36
2025-06-03QGEN45.286.3449.02.36
2025-06-04QGEN45.716.3449.62.36
2025-06-05QGEN45.566.3441.82.36
2025-06-06QGEN45.486.3442.92.36
2025-06-09QGEN46.176.3452.92.36
2025-06-10QGEN46.236.3444.72.36
2025-06-11QGEN46.736.3450.52.36
2025-06-12QGEN47.396.3452.52.36
2025-06-13QGEN47.096.3440.12.36
2025-06-16QGEN47.446.3448.12.36
2025-06-17QGEN46.576.3432.82.36
2025-06-18QGEN46.556.3444.02.36
2025-06-20QGEN46.766.3446.62.36
2025-06-23QGEN46.726.3443.42.36
2025-06-24QGEN47.226.3450.42.36
2025-06-25QGEN47.486.3447.12.36
2025-06-26QGEN48.026.6450.72.36
2025-06-27QGEN47.766.6440.42.36
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02QGEN0.002.672.82
2025-06-03QGEN0.002.672.82
2025-06-04QGEN0.002.672.82
2025-06-05QGEN0.002.672.82
2025-06-06QGEN0.002.672.82
2025-06-09QGEN0.002.752.82
2025-06-10QGEN0.002.752.82
2025-06-11QGEN0.002.752.97
2025-06-12QGEN0.002.752.97
2025-06-13QGEN0.002.752.97
2025-06-16QGEN0.004.032.97
2025-06-17QGEN0.004.032.97
2025-06-18QGEN0.004.032.97
2025-06-20QGEN0.004.032.97
2025-06-23QGEN0.00-0.782.97
2025-06-24QGEN0.00-0.782.97
2025-06-25QGEN0.00-0.782.97
2025-06-26QGEN0.00-0.782.63
2025-06-27QGEN0.00-0.782.63
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.55

Avg. EPS Est. Current Quarter

0.6

Avg. EPS Est. Next Quarter

0.58

Insider Transactions

Institutional Transactions

-0.78

Beta

0.69

Average Sales Estimate Current Quarter

523

Average Sales Estimate Next Quarter

515

Fair Value

46.73

Quality Score

70

Growth Score

70

Sentiment Score

78

Actual DrawDown %

23.7

Max Drawdown 5-Year %

-37.4

Target Price

50.14

P/E

114.45

Forward P/E

18.88

PEG

15.7

P/S

5.17

P/B

3.04

P/Free Cash Flow

20.46

EPS

0.42

Average EPS Est. Cur. Y​

2.36

EPS Next Y. (Est.)

2.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.68

Relative Volume

1.25

Return on Equity vs Sector %

-21.2

Return on Equity vs Industry %

-7.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

440.4
Qiagen N.V.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 5700
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
stock quote shares QGEN – Qiagen N.V. Stock Price stock today
news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QGEN – Qiagen N.V. yahoo finance google finance
stock history QGEN – Qiagen N.V. invest stock market
stock prices QGEN premarket after hours
ticker QGEN fair value insiders trading